Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Change in Receivables: 2019-2024

Historic Change in Receivables for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$3.2 million.

  • MDxHealth's Change in Receivables rose 173.95% to $545,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year increase of 81.67%. This contributed to the annual value of -$3.2 million for FY2024, which is 91.68% down from last year.
  • As of FY2024, MDxHealth's Change in Receivables stood at -$3.2 million, which was down 91.68% from -$1.7 million recorded in FY2023.
  • MDxHealth's Change in Receivables' 5-year high stood at $2.9 million during FY2020, with a 5-year trough of -$5.1 million in FY2022.
  • For the 3-year period, MDxHealth's Change in Receivables averaged around -$3.3 million, with its median value being -$3.2 million (2024).
  • Per our database at Business Quant, MDxHealth's Change in Receivables crashed by 270.35% in 2022 and then surged by 67.14% in 2023.
  • Over the past 5 years, MDxHealth's Change in Receivables (MRY) stood at $2.9 million in 2020, then plummeted by 148.51% to -$1.4 million in 2021, then tumbled by 270.35% to -$5.1 million in 2022, then skyrocketed by 67.14% to -$1.7 million in 2023, then plummeted by 91.68% to -$3.2 million in 2024.
  • Its last three reported values are -$3.2 million in FY2024, -$1.7 million for FY2023, and -$5.1 million during FY2022.